Aurora Cannabis (ACB) announced the availability of medical cannabis concentrates to patients in the U.K. These products are available to patients in Canada and Australia. The two novel cultivar-specific Aurora 1.2g resin cartridges have been developed from two proprietary cultivars.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACB:
- Aurora Cannabis management to meet virtually with Roth MKM
- TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside
- Aurora Cannabis Unveils Mildew-Resistant Cannabis Breakthrough
- Aurora Cannabis announces discovery of powdery mildew resistant cultivars
- Aurora Cannabis expands medical cannabis pastille offerings in Australia
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue